News Articles
Latest articles, insights, and updates from the blog.
Have a question about this topic?
Use the contact page when you need to send feedback, request a correction, or ask about the resource.
FDA Ketamine Crackdown: What Patients Should Know
FDA enforcement against illegal ketamine sellers is rising. Learn what this means for patients vetting legitimate telehealth ketamine providers.
Ketamine Eases Resistant Depression and Suicidal Ideation
New research highlights ketamine's promise for treatment-resistant depression and suicidal thoughts. What patients considering ketamine care should know.
NRx Gets FDA Expanded Access for Ketamine Protocol
NRx Pharmaceuticals received FDA Expanded Access for its ketamine-based protocol. Here's what this means for patients pursuing treatment for severe depression.
Brain Scans Could Predict Ketamine Success in Depression
New research shows brain imaging may predict which depression patients will respond best to ketamine therapy, advancing personalized treatment.
Ketamine Study Shows Depression Relief Within Hours
New research confirms single ketamine infusion provides rapid depression relief. What this means for online treatment options.
Ketamine Offers Fast Relief for Depression and Suicidal Thoughts
Medscape research confirms ketamine rapidly relieves depression and suicidal ideation. What it means for patients exploring online ketamine treatment.
Ketamine vs. TMS: Choosing the Right Depression Path
Medical Daily breaks down when ketamine or TMS is the right call for treatment-resistant depression and what patients can realistically expect.
New Trial: CBT After Esketamine Lowers Relapse Risk
CBT-ENDURE trial: pairing CBT with esketamine significantly reduces depression relapse and suicidal ideation. What online ketamine patients need to know.
CBT After Ketamine Cuts Relapse Risk, Trial Finds
The CBT-ENDURE trial shows adding 16 weeks of CBT after esketamine significantly improves outcomes for depression and suicidal ideation. What patients should know.
Your Antidepressant May Not Affect Ketamine Outcomes
New research finds concurrent antidepressant use doesn't significantly alter ketamine or esketamine outcomes — here's what that means for patients.
Ketamine Side Effects Data: What TRD Patients Need to Know
New clinical analysis urges smarter ketamine protocols for TRD—what side effect data and dropout rates mean for patients exploring online ketamine treatment.
What New NMDA Data Means for Ketamine Patients
New clinical guidance on NMDA receptor antagonists urges smarter dose optimization and faster switching. Here's what it means for online ketamine patients.
NMDA Antagonists for TRD: What the Data Means for You
New clinical data on NMDA receptor antagonists for TRD highlights side effect profiles, dropout rates, and why faster dose optimization matters for patients.